Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenosine Signaling in Primary and Metastatic Brain Tumors: Immune Suppression, Tumor Progression, and Therapeutic Opportunities.

Molecular neurobiology·2026
Same author

Targeting purinergic signaling and MTAP-associated metabolism in cancer: A functional immunometabolic convergence framework.

Biochemical pharmacology·2026
Same author

Genetic alterations in SUPT6H are associated with neurodevelopmental disorders.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

AES-NINDS Epilepsy Benchmarks Area IV: Comorbidities of Epilepsy - Where Are We and Where Will We Go?

Epilepsy currents·2026
Same author

Commonalities in gene expression and methylation changes across two rat models of acquired epilepsy.

Scientific reports·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Enzymes.

British journal of pharmacology·2025

Related Experiment Video

Updated: Feb 27, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

7.1K

Engineering Human Mesenchymal Stem Cells to Release Adenosine Using miRNA Technology.

Gaoying Ren1,2, Detlev Boison3

  • 1Department of Medicine, University of Washington, Seattle, WA, 98195, USA. reng@ohsu.edu.

Methods in Molecular Biology (Clifton, N.J.)
|July 5, 2017
PubMed
Summary

Researchers engineered human mesenchymal stem cells (hMSCs) to release adenosine, a cell-protective molecule. This approach successfully demonstrated neuroprotection in a mouse seizure model, highlighting potential for autologous implants.

Keywords:
AdenosineAdenosine kinaseCell therapyEpilepsyHuman mesenchymal stem cellsKainic acidLentivirusRNAi

More Related Videos

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
10:55

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Published on: March 8, 2019

8.7K
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
07:56

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Published on: November 16, 2018

7.3K

Related Experiment Videos

Last Updated: Feb 27, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

7.1K
Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
10:55

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Published on: March 8, 2019

8.7K
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
07:56

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Published on: November 16, 2018

7.3K

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Stem Cell Biology

Background:

  • Adenosine modulates metabolic activity and offers tissue protection.
  • Adenosine kinase (ADK) regulates adenosine levels.
  • Engineering adenosine-releasing stem cells offers therapeutic potential.

Purpose of the Study:

  • To downregulate ADK in human mesenchymal stem cells (hMSCs) using lentiviral RNA interference.
  • To assess the therapeutic efficacy of engineered hMSCs in a neuroprotection model.

Main Methods:

  • Constructed lentiviral vectors co-expressing miRNA against ADK and EmGFP reporter.
  • Transduced hMSCs and evaluated ADK downregulation and transduction efficiency.
  • Assessed graft survival and neuroprotective effects in a mouse seizure model.

Main Results:

  • Achieved up to 80% ADK downregulation and 98% transduction efficiency in hMSCs.
  • Engineered hMSCs maintained EmGFP expression through multiple passages.
  • Successfully demonstrated adenosine-dependent neuroprotection in vivo.

Conclusions:

  • Lentiviral-mediated ADK downregulation is effective for engineering therapeutic adenosine-releasing hMSCs.
  • Engineered hMSC grafts show promise for autologous implants and neuroprotection.
  • This strategy offers a potential new avenue for treating neurological disorders.